• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NewLink Genetics Corp

+ Add to Watchlist


20.9800 USD 0.7900 3.63%

As of 20:10:00 ET on 07/28/2014.

Snapshot for NewLink Genetics Corp (NLNK)

Open: 21.8200 Day's Range: 20.6800 - 21.8650 Volume: 130,736
Previous Close: 21.7700 52wk Range: 15.6100 - 53.4800 1-Yr Rtn: +21.41%

Stock Chart for NLNK

No chart data available.
  • NLNK:US 20.9800
  • 1D
  • 1M
  • 1Y
Interactive NLNK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NLNK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2400
Est. EPS (USD) (12/2014) -1.6920
Est. PEG Ratio -
Market Cap (M USD) 584.80
Shares Outstanding (M) 27.87
30 Day Average Volume 283,497
Price/Book (mrq) 7.3229
Price/Sale (ttm) 489.9579
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NLNK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NLNK

NewLink Genetics Corporation is a biopharmaceutical company. The Company develops and commercializes biologic and small-molecule immunotherapy products intended to treat a wide range of cancers. NewLink's products are designed to harness components of the patient's immune system to fight cancer either alone or in combination with other treatment regimens.

Charles J Link JrChairman/CEO/Chief Scientific OfcrNicholas N VahanianPresident/Chief Medical Ofcr
Gordon H Link JrCFO/SecretaryBrian WileyVP:Business Development
More Company Profile & Key Executives for NLNK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil